The candidate, Dr. Lakshmi Devi holds a Ph.D. degree from the University of Windsor, Canada and is a Professor in the Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine. She is currently funded by two independent grants; DA 08863 from NIDA/NIH-to study post-translational regulation of opioid receptors and NS 26880 from NINDS/NIH-to study regulation of opioid peptide biosynthesis. The long-term career goals of the candidate are to explore the contribution of opioid receptor characteristics to development of drug addiction and to identify molecules and pathways involved in this process with the intent of developing pharmacological tools to help in the prevention and/or treatment of drug abuse. Mount Sinai School of Medicine provides the intellectual environment for synergistic and collaborative interactions necessary to achieve this goal. The Senior Scientist Award will facilitate this by relieving considerable amount of teaching and administrative duties. This plan has the full support of the Department of Pharmacology and Biological Chemistry and of the School. The focus of studies in Dr. Devi's laboratory has been to explore molecular mechanisms modulating opioid receptor function. The objectives of the studies proposed in this grant application are to examine novel mechanisms such as receptor dimerization that can modulate opioid receptor function and to explore the involvement of processing enzymes in the regulation of neuropeptide levels.
The specific aims are: (i) to investigate heterodimerization between opioid receptor types in modulating receptor function, (ii) to explore the role of heterodimerization between opioid receptors and other GPCRsin modulating receptor function, (iii) to delineate the domains and residues of opioid receptors involved in dimerization and (iv) to explore the physiological involvement of processing enzymes in neuropeptide biosynthesis. The studies described in this grant application will provide critical information on early events that modulate opioid receptor function. Elucidation of the cellular pathways involved in modulation of receptor function is a compelling strategy for identifying appropriate pharmacological interventions for drug addiction.
|Stockert, Jennifer A; Devi, Lakshmi A (2015) Advancements in therapeutically targeting orphan GPCRs. Front Pharmacol 6:100|
|Stockton Jr, Steven D; Gomes, Ivone; Liu, Tong et al. (2015) Morphine Regulated Synaptic Networks Revealed by Integrated Proteomics and Network Analysis. Mol Cell Proteomics 14:2564-76|
|Kivell, Bronwyn; Uzelac, Zeljko; Sundaramurthy, Santhanalakshmi et al. (2014) Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology 86:228-40|
|Stockton Jr, Steven D; Devi, Lakshmi A (2014) An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure. Neuropsychopharmacology 39:88-103|
|Fujita, Wakako; Gomes, Ivone; Devi, Lakshmi A (2014) Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. Br J Pharmacol 171:4155-76|
|Yang, Lili; Rozenfeld, Raphael; Wu, Defeng et al. (2014) Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic Biol Med 68:260-7|
|Ferré, Sergi; Casadó, Vicent; Devi, Lakshmi A et al. (2014) G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev 66:413-34|
|Gupta, Achla; Gomes, Ivone; Wardman, Jonathan et al. (2014) Opioid receptor function is regulated by post-endocytic peptide processing. J Biol Chem 289:19613-26|
|Matsumoto, Kenjiro; Narita, Minoru; Muramatsu, Naotaka et al. (2014) Orally active opioid ?/? dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice. J Pharmacol Exp Ther 348:383-92|
|Toniolo, Elaine F; Maique, Estêfani T; Ferreira Jr, Wilson A et al. (2014) Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. Peptides 56:125-31|
Showing the most recent 10 out of 62 publications